tradingkey.logo

U.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa

ReutersDec 31, 2024 8:08 AM

- Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Axsome Therapeutics, Ducommun and Vacasa on Tuesday.

HIGHLIGHTS

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130

* Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating

* Vacasa Inc VCSA.O: Needham cuts to hold from buy

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130

* Axsome Therapeutics Inc AXSM.O: RBC raises target price to $138 from $132

* Cal-Maine Foods Inc CALM.O: Stephens raises target price to $88 from $82

* Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating

* Ducommun Inc DCO.N: RBC reinstates coverage with price target $72 vs $60

* Marinus Pharmaceuticals Inc MRNS.O: Baird raises target price to $0.55 from $0.50

* Vacasa Inc VCSA.O: Needham cuts to hold from buy

* Verastem Inc VSTM.O: BTIG raises target price to $20 from $13

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI